NPPA and atrial fibrillation: When mutant ANP (100 nM) was circulated in an ex vivo rat heart perfusion model, a significant reduction in action potential duration at 90% and effective refractory period were observed, thus directly showing the strong implications in the shortening of atrial action potentials in AF patients carrying NPPA mutation [266].